Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-007424
Filing Date
2022-02-23
Accepted
2022-02-23 17:45:23
Documents
1
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3866
  Complete submission text file 0000899243-22-007424.txt   5326
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Kaplan Brett (Reporting) CIK: 0001778763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 22665273